Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Acta Obstet Gynecol Scand ; 86(9): 1047-50, 2007.
Artigo em Inglês | MEDLINE | ID: mdl-17712643

RESUMO

BACKGROUND: To analyze the role of different measures in the treatment of acute moderate or severe symptomatic hydronephrosis in pregnancy. METHODS: Of the 18,130 women delivering at our institution between January 2000 and December 2004, 93 patients were admitted due to symptomatic hydronephrosis. Among these, 50 patients were diagnosed with moderate or severe hydronephrosis, and were randomly treated with conservative measures (25 patients) or double pigtail stent insertion (25 patients). Renal sonography, urinalysis, serum creatinine levels, white blood cell counts, and urine culture were done in all patients at first visit. The clinical and perinatal outcomes of the two groups were compared. RESULTS: The incidence of symptomatic hydronephrosis in pregnancy was 0.5% in our institution (93/18,130). The majority of the moderate or severe hydronephrosis (88%) cases were diagnosed after the first trimester. There were no statistically significant differences in the fetal body weight, Apgar score, preterm labor, and hospitalization day between the two groups. Among those receiving conservative treatment, five patients (5/25, 20%) failed to respond and were subsequently treated by double pigtail stent insertion successfully, compared with the surgical group, in which all patients were successfully relieved by double pigtail stent (p=0.018). Four patients receiving double pigtail stent insertion complained of stent discomfort and flank pain after the procedure (16%). CONCLUSION: Double pigtail stent insertion is effective for the treatment of moderate or severe symptomatic hydronephrosis in pregnancy, and showed a lower failure rate than the conservative treatment. However, due to the complications and discomfort with surgical treatment, conservative treatment should still be the first choice.


Assuntos
Hidronefrose/cirurgia , Hidronefrose/terapia , Complicações na Gravidez/cirurgia , Complicações na Gravidez/terapia , Stents , Adulto , Índice de Apgar , Nitrogênio da Ureia Sanguínea , Proteína C-Reativa/análise , Feminino , Peso Fetal , Idade Gestacional , Humanos , Hidronefrose/diagnóstico por imagem , Hidronefrose/patologia , Tempo de Internação , Contagem de Leucócitos , Trabalho de Parto Prematuro/epidemiologia , Dor/etiologia , Paridade , Gravidez , Complicações na Gravidez/diagnóstico por imagem , Estudos Prospectivos , Índice de Gravidade de Doença , Stents/efeitos adversos , Resultado do Tratamento , Ultrassonografia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA